Literature DB >> 2796591

Detection of high levels of immunoreactive human beta-1 interferon in sera from HIV-infected patients.

T Minagawa1, K Mizuno, S Hirano, M Asano, A Numata, M Kohanawa, A Nakane, K Hachimori, S Tamagawa, M Negishi.   

Abstract

We have examined human interferon beta-1 (HuIFN-beta 1) levels in the sera from patients with various diseases by using a newly developed highly sensitive enzyme-linked immunosorbent assay system (ELISA). High levels of HuIFN-beta 1 were detected in the sera from Human Immunodeficiency Virus-I (HIV-I) infected patients, especially of asymptomatic carriers. The serum level of HuIFN-beta 1 may be a good indicator of HIV-I infection and of other immunological disorders.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2796591     DOI： 10.1016/0024-3205(89)90147-1

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


  9 in total

1.  Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells.

Authors:  Jean-Philippe Herbeuval; Andrew W Hardy; Adriano Boasso; Stephanie A Anderson; Matthew J Dolan; Michel Dy; Gene M Shearer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-20       Impact factor: 11.205

2.  Suppressor of cytokine signaling 3 inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages.

Authors:  Lisa Nowoslawski Akhtar; Hongwei Qin; Michelle T Muldowney; Lora L Yanagisawa; Olaf Kutsch; Janice E Clements; Etty N Benveniste
Journal:  J Immunol       Date:  2010-07-14       Impact factor: 5.422

3.  Induction of alpha interferon by human immunodeficiency virus type 1 in human monocyte-macrophage cultures.

Authors:  J Szebeni; C Dieffenbach; S M Wahl; C N Venkateshan; A Yeh; M Popovic; S Gartner; L M Wahl; M Peterfy; R M Friedman
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

4.  Innate immune responses and control of acute simian immunodeficiency virus replication in the central nervous system.

Authors:  Sheila A Barber; David S Herbst; Brandon T Bullock; Lucio Gama; Janice E Clements
Journal:  J Neurovirol       Date:  2004       Impact factor: 2.643

5.  Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers.

Authors:  Gareth A D Hardy; Scott Sieg; Benigno Rodriguez; Donald Anthony; Robert Asaad; Wei Jiang; Joseph Mudd; Timothy Schacker; Nicholas T Funderburg; Heather A Pilch-Cooper; Robert Debernardo; Ronald L Rabin; Michael M Lederman; Clifford V Harding
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

6.  Induction of innate immune responses by SIV in vivo and in vitro: differential expression and function of RIG-I and MDA5.

Authors:  Juliene G Co; Kenneth W Witwer; Lucio Gama; M Christine Zink; Janice E Clements
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

Review 7.  Blocking type I interferon production: a new therapeutic option to reduce the HIV-1-induced immune activation.

Authors:  Moritz Ries; Kathrin Pritschet; Barbara Schmidt
Journal:  Clin Dev Immunol       Date:  2011-11-29

Review 8.  Human natural interferon-alpha producing cells.

Authors:  P Fitzgerald-Bocarsly
Journal:  Pharmacol Ther       Date:  1993-10       Impact factor: 12.310

9.  Gut-Associated Plasmacytoid Dendritic Cells Display an Immature Phenotype and Upregulated Granzyme B in Subjects with HIV/AIDS.

Authors:  Sergei V Boichuk; Svetlana F Khaiboullina; Bulat R Ramazanov; Gulshat R Khasanova; Karina A Ivanovskaya; Evgeny Z Nizamutdinov; Marat R Sharafutdinov; Ekaterina V Martynova; Kenny L DeMeirleir; Jan Hulstaert; Vladimir A Anokhin; Albert A Rizvanov; Vincent C Lombardi
Journal:  Front Immunol       Date:  2015-09-24       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.